MDT three-lens brief

Evidence-based stock research on MDT. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

Get full MDT research How the three lenses work

52-week rangeas of Jul 10

$73.31$82.95$106.33

Performance

-0.3%

+1.5%

-4.9%

-14.9%

YTD

-13.6%

-7.2%

—

MDT · Nightly brief

Steady

Outperforming SPY by 8.8pp over 30 days.

Outperforming SPY by 8.8pp over 30 days.
Analyst mean target $97.73 — 18% above current (26 analysts).

MDT closed at $82.95 (+0.68%) as of 2026-07-10. Market cap: $106.18B. P/E (trailing) 22.2. Price is above the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 8.8pp over 30 days.; analyst mean target $97.73 — 18% above current (26 analysts).. Last quarter: Revenue $9.81B, net income $1.24B, free cash flow $4.63B.

Market ✓· Fundamentals ✓

Informational only · Not investment advice

Three-lens method

Why three lenses on MDT, not one.

A single reasoning model has blind spots it doesn’t know about. We examine MDTacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology

Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/MDT"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath MDT brief"></iframe>

Also on ClearPath

Methodology

The five-stage pipeline

Compare

ClearPath vs. big dashboards

Transparency

Public track record